ASKFIRST
LIVE

Serial Number

98201386

Owner

Asklepios BioPharmaceutical, Inc.

Attorney

Kristen Mollnow Walsh

First Use Date

Jun 14, 2020

Filing Date

Sep 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ASKFIRST Trademark

Serial Number: 98201386 • Registration: 8064544

ASKFIRST is a trademark filed by Asklepios BioPharmaceutical, Inc. on September 28, 2023. The trademark is classified under Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Asklepios BioPharmaceutical, Inc. (10 trademarks)

20 T.W. Alexander Drive, Suite 110
Research Triangle Park, NC 27709

Entity Type: 03

Trademark Details

Filing Date

September 28, 2023

Registration Date

December 16, 2025

First Use Anywhere

June 14, 2020

First Use in Commerce

June 14, 2020

Published for Opposition

January 28, 2025

Goods & Services

Promoting collaboration between scientists, technicians, clinical specialists, patients, and their families to achieve advances in therapeutics, technology, regulatory requirements, and public policy in the field of healthcare, genetic disease, gene therapy, and clinical trials

Providing patient advocate services in the field of genetic disease, gene therapy, and potential curative therapies; providing personal support services for patients, namely, emotional counseling and emotional support by providing personal emotional support information in the fields of genetic disease, gene therapy, and potential curative therapies; providing patient advocacy and personal emotional support services to potential participants and participants in clinical trials for genetic diseases and gene therapy; providing information in the field of personal emotional support of gene therapy patients and patients' families

Filing History

TEAS SECTION 7 REQUEST RECEIVED
Jan 15, 2026 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 16, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 16, 2025 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Nov 21, 2025 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 21, 2025 AITU
NOTICE OF ALLOWANCE CANCELLED
Oct 1, 2025 IUCN
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 1, 2025 EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Apr 14, 2025 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 25, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 7, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 9, 2024 GNFN
FINAL REFUSAL E-MAILED
Dec 9, 2024 GNFR
FINAL REFUSAL WRITTEN
Dec 9, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2024 CRFA
ASSIGNED TO LIE
Nov 4, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 8, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 8, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 8, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 8, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 8, 2024 COAR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 8, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 8, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 8, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 2, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 11, 2023 NWOS
NEW APPLICATION ENTERED
Oct 2, 2023 NWAP